Category Archives: Health Care

NMC Healthcare appoints Snowflake to advance real-time analytics and patient care in the UAE

Abu Dhabi, UAE – 28 August 2025 – NMC Healthcare group (“NMC”), a leading integrated private healthcare provider in the United Arab Emirates, is using Snowflake, the AI Data Cloud company to transform NMC’s digital and operational processes, following a signing event held at NMC’s Abu Dhabi headquarters.

NMC will leverage Snowflake’s platform to enhance point-of-care decision-making and improve patient  experiences through real-time, AI-powered data analytics. By centralising operational and healthcare data across the organisation, NMC will deliver faster, more accurate insights across its national network of 70 medical facilities. The move will support more informed decision-making and more robust systems in line with internal and external data governance best practices, ultimately improving care delivery for the 5.5 million patients NMC serves annually.

Continue reading NMC Healthcare appoints Snowflake to advance real-time analytics and patient care in the UAE

RAK Hospital Opens Registrations for 3-Month Nationwide Diabetes Challenge 2025

RAK Diabetes Challenge 2025 Encourages Natural Diabetes Reversal; Top Winners to Receive AED 20,000 in Prizes

Ras Al Khaimah, UAE – August 22, 2025 – One of the UAE’s most impactful public health movements is back. RAK Hospital, in collaboration with Ministry of Health and Prevention (MOHAP) – Ras Al Khaimah, proudly announces the 4th edition of the RAK Diabetes Challenge (RAKDC 2025)— a nationwide wellness campaign designed to combat the alarming diabetes epidemic through lifestyle transformation, education, and community support.

Having transformed thousands of lives over the past three editions by reducing key diabetes biomarkers — HbA1c and BMI — this three-month campaign aims to be a guiding light for lifestyle change. It highlights the pivotal role of diet and regular exercise in not just managing, but potentially reversing, diabetes type-2 diabetes. Registration is free and is now open until August 31 at www.rakdiabeteschallenge.com

Continue reading RAK Hospital Opens Registrations for 3-Month Nationwide Diabetes Challenge 2025

Cleveland Clinic Abu Dhabi provides advanced first-of-its-kind stroke treatment in MENA region

  • Cleveland Clinic Abu Dhabi introduces innovative Artisse Intrasaccular Flow Modulator for stroke treatment.
  • As designated Center of Excellence for stroke, the hospital continues to expand access to safer, minimally invasive treatments for complex neurovascular conditions.
  • The hospital’s multidisciplinary team of neurological experts delivers highly specialized care using advanced imaging and catheter-based precision to reduce surgical risks and improve long-term outcomes.

Abu Dhabi, August 19, 2025: Cleveland Clinic Abu Dhabi has set a new standard in the treatment of brain aneurysms in the Middle East and North Africa (MENA) region, adopting the first Artisse Intrasaccular Flow Modulator, a novel medical implant for wide-necked intracranial aneurysms. Designated by the Department of Health – Abu Dhabi as a Centre of Excellence (CoE), this milestone underscores the hospital’s position for stroke as it continues to advance medical technology and deliver world-class care for patients.

Continue reading Cleveland Clinic Abu Dhabi provides advanced first-of-its-kind stroke treatment in MENA region

Response Plus Medical, Austability sign strategic partner non-financial MoU

Abu Dhabi, August 18, 2025: Response Plus Medical Services LLC (RPM), a subsidiary of Response Plus Holding PJSC – the largest pre-hospital care and emergency medical services provider in the region, has signed a strategic partner non-financial Memorandum of Understanding (MoU) with Austability Group Ltd, delivering world class expeditionary integrated base operational support services across the globe.

Continue reading Response Plus Medical, Austability sign strategic partner non-financial MoU

Lilly’s oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity

In ATTAIN-1, the investigational once-daily oral pill showed significant efficacy, and a safety and tolerability profile consistent with injectable GLP-1 therapies at 72 weeks

Orforglipron achieved the primary and all key secondary endpoints, including demonstrating improvements in a number of cardiovascular risk factors

With these results, Lilly is on track to submit orforglipron to global regulatory agencies by year-end and is making substantial investments to meet anticipated demand at launch

Continue reading Lilly’s oral GLP-1, orforglipron, delivers weight loss of up to an average of 27.3 lbs in first of two pivotal Phase 3 trials in adults with obesity